Investing.com - Ocugen reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that was inline with expectations.
Ocugen announced earnings per share of $-0.100 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.094 on revenue of $0.00.
Ocugen 's are down 35% and is trading at $1.645 , still down 84.18% from its 52 week high of $10.40 set on Monday, November 8, 2021.
Ocugen shares gained 7.52% to trade at $1.645 in intra-day trade the report.
Ocugen follows other major Healthcare sector earnings this month
Ocugen's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar